Sabra Health Care REIT, Inc.
SBRAReal EstateNASDAQREIT - Healthcare Facilities · Last scanned Oct 24, 2026
Scan Results
Daily timeframeSabra Health Care REIT, Inc. operates as a self-administered, self-managed real estate investment trust that, through its subsidiaries, owns and invests in real estate serving the healthcare industry throughout the United States. Valued at $5.00B, SBRA is a mid-cap name in its sector. Sabra Health Care REIT, Inc.
Market Cap
$5.00B
Beta
0.62
P/E (TTM)
78.24
P/E (Fwd)
24.15
EPS (TTM)
$0.25
EPS (Fwd)
$0.81
ROE
2.4%
ROA
1.9%
Cash
$246.3M
Total Debt
$2.63B
Free CF
$155.1M
52W Change
8.2%
Annual Financials
Cash vs Debt
Where SBRA stands vs its 150-day and 200-day moving averages
As of the October 19, 2026 close, SBRA finished 2.27% below its 150-day moving average ($19.79) and 1.12% below its 200-day moving average ($19.56). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is SBRA overbought or oversold?
At the October 19, 2026 close, SBRA's RSI(14) was 38.4, in neutral territory (between 30 and 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
The company holds $246.3M in cash, though total debt stands at $2.63B. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. Free cash flow comes in at $155.1M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. ROE of 2.4% points to modest capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. ROA of 1.9% is on the lower side, which is common in asset-heavy industries. Revenue has grown from $624.8M (2022) to $774.6M (2025), reflecting a 24% increase over the period.
SBRA's low beta indicates it tends to be less volatile than the broader market, which may suit investors seeking more stable price behavior. The debt-to-cash ratio suggests meaningful leverage on the balance sheet, a factor worth monitoring if credit conditions tighten. The elevated P/E ratio means the stock is priced for significant future growth. If earnings disappoint, the price correction could be sharp. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing SBRA.